Avadel Pharmaceuticals   Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: Dublin Ireland (1990)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2020
NCT04451668
First Marketed Drug
2013
neostigmine (bloxiverz)
First NDA Approval
2013
neostigmine (bloxiverz)
Last Known Activity
2020

Mergers & Acquisitions

Historical Acquisition Tree